The Chicago Entrepreneur

Novo Nordisk now has more than 130,000 weight-loss prescriptions as it hikes financial outlook

Novo Nordisk said its Wegovy injectable drug for weight loss now has more than 130,000 weekly prescriptions in North America alone after boosting supplies to meet insatiable demand.

Previous post Shell launches $3.5 billion buyback after earning $7.7 billion
Next post Shares of Nio soar more than 20% as EV deliveries more than double in April